P450: ALDH1A AS A THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA
Main Authors: | Mehak Shaikh, Muhube Yazir, Céline Baier, Andrada Constantineascu, Julie Vackova, Miroslava K. Adamcova, Mileidys Perez-Alea, Meritxell Alberich-Jorda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968708.47762.a9 |
Similar Items
-
Simultaneous deletion of ORMDL1 and ORMDL3 proteins disrupts immune cell homeostasis
by: Livia Demkova, et al.
Published: (2024-04-01) -
An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment
by: Cristian Sandoval, et al.
Published: (2023-03-01) -
The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia
by: Garrett M. Dancik, et al.
Published: (2023-05-01) -
Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation
by: Katerina Rejlova, et al.
Published: (2018-01-01) -
Single-Cell Transcriptome Analysis of Acute Myeloid Leukemia Cells Using Methanol Fixation and Cryopreservation
by: Lamia Madaci, et al.
Published: (2023-12-01)